PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar at 3-1/2-month high on elevated yields, euro soft after ECB

Fri, 27th Apr 2018 02:04

* Dollar helped by higher yields; lack of trade,geopolitical news

* Euro loses steam after Draghi sounds cautious on economy

* Yen capped, sterling helped by Takeda's bid to buy Shire

By Hideyuki Sano

TOKYO, April 27 (Reuters) - The dollar held near a3-1/2-month high against a basket of currencies on Friday ashigher U.S. yields have prompted unwinding of big shortpositions in the currency while the euro was hampered by adovish tone from the European Central Bank.

The dollar's index against six major currencies hit ahigh of 91.639, its strongest level since mid-January asinvestors have warmed to the greenback thanks to attractiveTreasury yields.

The benchmark 10-year U.S. Treasuries had hitthe psychologically important three percent mark on combinationof worries about inflation and increased debt supplies as aresult of President Donald Trump's tax cuts and spending plans.

Earlier this year, the correlation between U.S. yields andthe dollar broken down as investors focused more on tradefrictions and geopolitical issues, with currencies largelydriven by Trump's tweets than by economic data and yields.

But so far this week, as concerns over U.S.-China tradetensions have ebbed somewhat, the markets have turned theirattention to interest rate plays.

In addition, speculators' net dollar short position incurrency futures in Chicago, a closely-watchedindicator on market positioning, had hit a 6-1/2-year high,suggesting some short-covering will be due.

"There is an element of positioning unwind underpinning therecent dollar strength... The currencies that had the largestnet long positions against the dollar are the ones that havedeclined the most," wrote analysts at ANZ wrote.

The euro, in which speculators had a record long position,fell to $1.20965 in the previous session, its lowestlevel since Jan. 12. It last stood at $1.21805, and is down 1.5percent on the week.

The common currency slid on Thursday after ECB chief MarioDraghi acknowledged evidence of a "pull-back" from exceptionalgrowth readings seen around the turn of the year, although thecentral bank sought to bolster expectations for a gradualwithdrawal of its monetary stimulus.

The dollar changed hands at 109.33 yen, having risento a 2-1/2-month high of 109.49 yen earlier in the week. So farthis week, it has gained 1.5 percent.

The yen's weakness is likely to reflect expectations ofyen-selling as drugmaker Takeda Pharmaceutical ispushing to buy London-listed Shire in a $64 billiondeal, which would be the biggest Japanese acquisition of aforeign company.

"Given the May 8 deadline of the deal, you would need to bereally courageous to go long on the yen until then," said YukioIshizuki, senior strategist at Daiwa Securities.

In contrast, the pound has been relatively well-supported. It last stood at $1.3915, down 0.6 percent sofar this week.

Against the yen, it was fetching 152.14 yen, up0.9 percent this week.

Elsewhere, the Australian dollar hit a 4-1/2-monthlow of $0.75465.

The Swedish crown weakened, hitting its lowest level sinceNovember 2009 against the euro, after the Swedishcentral bank Riksbank pushed back its rate hike plan due toworries about sluggish inflation.(Editing by Shri Navaratnam)

More News
25 Oct 2018 15:20

TOP NEWS: Shire Seeks US Approval To Make Flexbumin At New Facility

LONDON (Alliance News) - Pharmaceutical company Shire PLC on Thursday said it has filed a submission to the US Food & Drug Administration for approval to manufacture Flexbumin at its new is as

Read more
23 Oct 2018 16:25

MOVES-JPMorgan reshuffles healthcare group, co-head departs -sources

By Greg Roumeliotis and Liana B. Baker Oct 23 (Reuters) - JPMorgan Chase & Co has appointed Mike Gaito as global co-head of healthcare investment banking after Jeff Stute, who held that

Read more
19 Oct 2018 14:38

Shire's lanadelumab gets one step closer to European approval

(Sharecast News) - Rare disease-focussed biotechnology company Shire announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of marketing authorisation of 'lanadelumab' injection, for the routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.

Read more
18 Oct 2018 09:26

UPDATE 1-Takeda gets Japanese approval for $62 bln Shire purchase

Oct 18 (Reuters) - Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to a it

Read more
1 Oct 2018 11:24

Schroder Japan Growth Outperforms Benchmark In Full Year

LONDON (Alliance News) - Schroder Japan Growth Fund PLC said on Monday it outperformed its benchmark in its recently ended financial year due to a robust performance in the first half, in spite of

Read more
28 Sep 2018 06:23

UK Stocks-Factors to watch on Sept 28

Sept 28 (Reuters) - Britain's FTSE 100 index is seen opening 8 points higher at 7,553 on Friday, according to financial bookmakers. * SHIRE: Japan M&A volumes are set to break a 19-year-old

Read more
28 Sep 2018 04:09

Morning News Call - India, September 28

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_09282018.pdf If you would like to receive this newsletter via email, please at: TO

Read more
27 Sep 2018 17:53

UPDATE 1-FTSE rises to 4-week high helped by sterling weakness

* FTSE 100 up 0.5 pct * Higher crude lifts oil stocks, hits airlines * TUI sticks to forecasts, shares gain (Adds details, closing prices) By Danilo Masoni MILAN, Sept

Read more
21 Sep 2018 11:26

Shire Gets Japanese Approval For Rare Genetic Disease Drug Firazyr

LONDON (Alliance News) - Pharmaceutical company Shire PLC on Friday said it has been granted manufacturing and marketing authorisation in Japan for its hereditary angioedema drug, Japanese of has

Read more
21 Sep 2018 07:19

Shire gets approval for hereditary angioedema treatment in Japan

(Sharecast News) - Rare disease specialist Shire announced on Friday that the Ministry of Health, Labour and Welfare (MHLW) in Japan has granted manufacturing and marketing authorisation for its 'FIRAZYR' icatibant injection, for the acute treatment of hereditary angioedema (HAE) attacks in adult patients with HAE.

Read more
17 Sep 2018 06:41

UK Stocks-Factors to watch on Sept 17

Britain's FTSE 100 index is seen opening 11 points lower at 7,293 on Monday, according to financial bookmakers. * GOLD: Gold inched up on Monday as bargain-hunters bought the metal after prices

Read more
14 Sep 2018 17:28

UPDATE 1-FTSE tracks Europe higher; Shire shines

* FTSE 100 up 0.3 pct * Shire gains after China nod to Takeda deal * Housebuilders in focus * Investec rallies on spin-off plans (Adds closing) By Danilo Sept 14 - top

Read more
14 Sep 2018 12:01

LONDON MARKET MIDDAY: Stocks Higher As Shire And Whitbread Gain

LONDON (Alliance News) - Stocks in London were higher at midday on Friday with Shire and Whitbread performing well among FTSE 100 constituents, while in the FTSE was

Read more
14 Sep 2018 10:32

WINNERS & LOSERS SUMMARY: Housebuilders Hit By No-Deal Brexit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 1.8%. Takeda Pharmaceutical said it had in of

Read more
14 Sep 2018 10:16

FTSE tracks Europe higher on trade hopes; Shire shines

(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 up 0.1 pct * Shire gains after China nod to Takeda deal * Housebuilders under Investec on -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.